Delicia Honen Yard, Author at Renal and Urology News - Page 29

Delicia Honen Yard

All articles by Delicia Honen Yard

Dual Regimen Superior for Metastatic RCC

Bevacizumab used in combination with interferon alfa as a first-line treatment for metastatic renal cell carcinoma (RCC) nearly doubled progression-free survival in patients taking part in an international phase III trial.

Next post in News